Moricin-1

General Information


DRACP ID  DRACP03438

Peptide Name   Moricin-1

Sequence  AKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKH

Sequence Length  42

UniProt ID  O96059  P82818 

PubChem CID  Not available

Origin  Animalia

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  1KV4 

Predicted Structure  DRACP03438

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C208H358N62O51

Absent amino acids  CEMQWY

Common amino acids  K

Mass  527503

Pl  12.03

Basic residues  12

Acidic residues  1

Hydrophobic residues  18

Net charge  11

Boman Index  -5543

Hydrophobicity  -20.95

Aliphatic Index  100

Half Life 
  Mammalian: 7.2 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Antimicrobial peptide moricin induces ROS mediated caspase-dependent apoptosis in human triple negative breast cancer via suppression of notch pathway

Doi Not available

Year  2022

Literature 2

Pubmed ID 8530391

Title  Moricin, a novel type of antibacterial peptide isolated from the silkworm, Bombyx mori

Doi Not available

Year  1995

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  2135

DRACP is developed by Dr.Zheng's team.